Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.48 |
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.36 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19999148 | 0.89 | CYP2C19 (0.56) | CYP2C19PPARGPPARASMN1; SMN2HCAR2 | |
| SCHEMBL17964196 | 0.89 | CYP2C19 (0.56) | CYP2C19PPARGPPARASMN1; SMN2HCAR2 | |
| SCHEMBL28948579 | 0.88 | CYP2C19 (0.54) | CYP2C19PPARGPPARASMN1; SMN2HCAR2 | |
| SCHEMBL27983309 | 0.86 | CYP2C19 (0.53) | CYP2C19PPARGPPARASMN1; SMN2HCAR2 | |
| SCHEMBL22436286 | 0.86 | CYP2C19 (0.53) | CYP2C19PPARGPPARASMN1; SMN2HCAR2 | |
| SCHEMBL18426754 | 0.86 | CYP2C19 (0.53) | CYP2C19PPARGPPARASMN1; SMN2CYP2D6 | |
| SCHEMBL12143882 | 0.86 | CYP2C19 (0.53) | CYP2C19PPARGPPARASMN1; SMN2HCAR2 | |
| SCHEMBL28435120 | 0.85 | CYP2C19 (0.51) | CYP2C19PPARGPPARASMN1; SMN2LMNA | |
| SCHEMBL9860853 | 0.83 | HCAR2 (0.58) | CYP2C19PPARGPPARASMN1; SMN2HCAR2 | |
| SCHEMBL9709424 | 0.83 | HCAR2 (0.58) | CYP2C19PPARGPPARASMN1; SMN2HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2991655-B1 | COMPOSITIONS AND METHODS FOR ALTERING SECOND MESSENGER SIGNALING | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2024-04-10 | — | — | EP | claimed |
| EP-3092220-B1 | VITAMIN C PRODRUGS AND USES THEREOF | UNIV FLORIDA (US) | 2021-01-20 | — | — | EP | claimed |
| EP-2016044-B1 | PENTACYCLINE DERIVATIVES FOR THE TREATMENT OF INFECTIONS | HARVARD COLLEGE (US) | 2020-06-10 | — | — | EP | claimed |
| CN-117794560-A | Stapled peptides and methods thereof | 弗格制药有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117229172-A | Diquinine compound and synthetic method and application thereof | 三峡大学 | 2023-12-15 | — | — | CN | disclosed |
| CN-116323638-A | Stapled peptides and methods thereof | 弗格制药有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-115066263-A | Directed conjugation techniques | 克莱奥药品有限公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-114585737-A | Oligonucleotide compositions and methods of use thereof | 波涛生命科学有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-114585370-A | Oligonucleotide compositions and methods of use thereof | 波涛生命科学有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-114502177-A | Oligonucleotide compositions and methods of use thereof | 波涛生命科学有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-114401719-A | Inhibitors of cyclin-dependent kinase 7 and uses thereof | 达纳-法伯癌症研究所股份有限公司 | 2022-04-26 | — | — | CN | disclosed |
| WO-2016120890-A1 | AN ENANTIOSELECTIVE PROCESS FOR THE SYNTHESIS OF (2S,4R)-4-HYDROXYPIPECOLIC ACID | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-08-04 | — | — | WO | disclosed |
| US-20150044554-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-02-12 | — | — | US | disclosed |
| US-20130216919-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-08-22 | — | — | US | disclosed |
| EP-2618418-A1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2013-07-24 | — | — | EP | disclosed |
| US-20130071731-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-03-21 | — | — | US | disclosed |
| US-20130071730-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-03-21 | — | — | US | disclosed |
| EP-2571089-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION, AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2013-03-20 | — | — | EP | disclosed |
| EP-2571090-A1 | NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2013-03-20 | — | — | EP | disclosed |
| US-4532233-A | Antibiotics | SHIONOGI & CO., LTD. (JP) | 1985-07-30 | — | — | US | disclosed |